OS Therapies completes second closing of $1.05M private placement

OS Therapies Inc

Second closing sold 263,250 units at $4.00 each, raising $1.053 million in gross proceeds.
Each unit consists of one share of Series A Convertible Preferred Stock and a warrant to purchase one common share.
Amendment to securities purchase agreement allows multiple closings up to $10 million, with final closing by Feb 15, 2025.
Investors in second closing include Tichenor Ventures, LLC; placement agent Brookline Capital Markets received $35,157 cash fee.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.